• Media Centre
  • Investor relations
  • Client area
  • Client area
  • Stewardship policy
  • Annual reports service

Form of Proxy

INDAPTUS THERAPEUTICS, INC.

Notes

No. Proposition For Against Abstain
1

DIRECTOR Mark J. Gilbert, M.D.

2

DIRECTOR Hila Karah

3

DIRECTOR R. E. Martell, M.D Ph.D

4

Ratification of the appointment of Haskell & White LLP as our independent registered public accounting firm for the year ending December 31, 2025.

5

To approve, on an advisory basis, the compensation paid to our named executive officers.

6

To approve an amendment to our Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split with respect to our issued and outstanding common stock at a ratio of 1-for-5 to 1-for-28 (the Range), with the ratio within such Range to be determined at the discretion of our Board of Directors.